LymphomaArchives
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study
Lymphoma 1 min.
Effective treatments with deep and durable responses for relapsed or refractory marginal zone lymphoma (MZL) are lacking. The of the primary analysis from the MZL cohort of TRANSCEND FL was to evaluate the efficacy and safety of the CD19-directed chimeric antigen receptor (CAR) T-cell therapy lisocabtagene...
Operational efficiencies of using one vs multiple bispecific antibodies for diffuse large B-cell lymphoma and follicular lymphoma in the US
Lymphoma 1 min.
To quantify the time- and cost-savings to US oncology practices from using a single bispecific antibody (bsAb) for both relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) compared with using two separate single-indication therapies. ...
Small bowel lymphoma presenting with frequent perforation: a single center experience focusing on the monomorphic epitheliotropic intestinal T-cell lymphoma
Lymphoma 5 min.
Primary small bowel malignancies are very rare though the small bowel accounts for more than 90% of the mucosal surface of the whole digestive tract [1]. The initial symptoms of small bowel tumors are generally vague and non-specific. Intermittent abdominal pain, occult bleeding with anemia, and obstruction...
Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland
Lymphoma 5 min.
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive form of non-Hodgkin lymphoma. In approximately 90% of the PCNSL cases, the histological subtype is diffuse large B-cell lymphoma (DLBCL) [1]. DLBCL is a subtype of LBCL, a diverse group of aggressive B-cell lineage neoplasms [2]....
Development and validation of a predictive model for extranodal natural killer/T-cell lymphoma
Lymphoma 6 min.
Extranodal natural killer/T-cell lymphoma (ENKTL) is an Epstein-Barr virus (EBV)-related non-Hodgkin lymphoma, primarily prevalent in East Asia and among indigenous populations of Central and South America1. Non-anthracycline-based chemotherapy, usually with L-asparaginase and/or radiation therapy, is...
